Ameriderm Laboratories, Ltd. FDA Inspection Record

FEI 3001452902 · Inspections, Form 483s, warning letters and import refusals

Ameriderm Laboratories, Ltd. is an FDA-inspected facility (FEI 3001452902) located in Paterson, NJ, US. RegDataLab tracks 2 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Feb 13, 2013: Official Action Indicated (OAI)
Inspections on record
2 (1 OAI, 1 VAI)
Last OAI inspection
Feb 13, 2013
Warning letters
1 listed by FDA for this FEI, latest Dec 2, 2013

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Feb 13, 2013Official Action Indicated (OAI)Written procedures not established/followed (21 CFR 211.67(b))
Absence of Written Procedures (21 CFR 211.100(a))
Handling and Storage to Prevent Contamination (21 CFR 211.80(b))
Representative Samples Criteria (21 CFR 211.84(b))
and 8 more
Jun 29, 2011Voluntary Action Indicated (VAI)Authority lacking to review records, investigate errors (21 CFR 211.22(a))
Procedures not in writing, fully followed (21 CFR 211.22(d))
Absence of Written Procedures (21 CFR 211.100(a))
Representative Samples (21 CFR 211.84(b))
and 8 more

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

3 records behind this number
RecordDatePoints x age weightAdds
Warning letter on FDA's dashboard, which does not show close-outsDec 2, 201310 years or older, so it adds no points0
Inspection classified OAIFeb 13, 201310 years or older, so it adds no points0
Inspection classified VAIJun 29, 201110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Ameriderm Laboratories, Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Ameriderm Laboratories, Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Ameriderm Laboratories, Ltd.
Location
Paterson, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.